| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Kendle has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 27-Nov-2009 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (KNDL). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (KNDL). | 5 |
$18 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for KNDL. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| KNDL: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | KENDLE INTERNATIONAL INC (KNDL=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Health Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Outsourcing & Offshoring Industry Market Research and Competitive Analysis 2010 | 511 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Consulting Industry Market Research and Competitive Analysis 2009 | 408 |
$299 |
1.48% Nasdaq 
Research Reports
